Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Envista Holdings Corporation Common Stock (NVST) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Envista Holdings Corporation Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Envista Holdings Corporation Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Envista Holdings Corporation Common Stock trades at $22.45 (market cap $3.64B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.9× Envista Holdings Corporation Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Envista Holdings Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Envista Holdings Corporation Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

NVSTRDY
Market Cap
$3.64B$10.61B
Volume
2,411,6973,738,869
Sector
HealthHealth
52-Week High
$30.26$15.38
52-Week Low
$18.95$11.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$4.10B$10.51B
Dividend Yield
—0.65%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVST
100% Buy0% Sell
Avg holding period · 0 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Envista Holdings Corporation Common Stock

Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.

Read more on NVST →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →